FEATURE ARTICLES
Five nations are collaborating on a work-sharing program to reduce regulatory duplication in drug development.
- 3 Ways To Deliver A Pharma 4.0 Facility
- How To Improve Sponsor–CMO Collaboration Around Digital Deviations
- Innovation, Growth (and Happiness) Projected for Pharma
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Shaping The Future Of GLP-1 Quality
- M&A In GLP-1 Technology: Practical Recommendations And Best Practices
- Makary Talks Faster Drug Reviews, 'Continuous Trials,' DTC Ads
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-1790844511-assay-laboratory-machine-plate]( "Three Key Actions To Minimize Dead Volumes")
Three Key Actions To Minimize Dead VolumesMinimizing liquid dead volume helps labs conserve costly reagents and scarce samples while boosting assay throughput. Learn how advanced liquid level detection technologies are driving efficiency.
-
Quality: The Link Between Platform, Processes, And Patients2/18/2025
Quality management in healthcare and life sciences is crucial for optimizing patient health. Learn how modern quality management systems optimize patient outcomes, enhance safety, and drive operational efficiency.
-
A Powerful Non-Destructive Tool For Tablet Characterization10/6/2025
Discover how X-ray micro-CT provides vital, non-destructive analysis of a tablet’s internal 3D physical structure. This structural insight is essential for troubleshooting defects and confirming performance.
-
Is Mannitol Hemihydrate Detrimental To Protein Stability?10/16/2024
Maintaining an amorphous excipient matrix is crucial for protein stability. Learn about the importance of storage conditions in managing mannitol hemihydrate dehydration and ensuring protein stability.
-
Revolutionizing Drug Discovery From "Undruggables" To AI6/10/2024
Explore four current trends in drug discovery, how each trend addresses some of the most crucial challenges in drug discovery, and the obstacles to their widespread adoption.
-
Small Molecule API Production: Unveiling The Impact Of Fermentation5/16/2024
Technological developments have led to growth in the suitability of fermentation for a myriad of applications. Explore the impact of the evolution of synthetic biology and supporting technologies on modern fermentation practice.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Downstream Processing Of A Mid-Scale Lentiviral Vector Batch
- Enhance Cell Line Development With Rapid Whole-Well Imaging
- CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics
- Fully Automated Cell Culture Passaging And Expansion
- Moving Established Methods From A Legacy HPLC Instrument To A New HPLC system
NEWSLETTER ARCHIVE
- 11.20.25 -- Optimize Formulation And Integrity Workflows
- 11.20.25 -- 3 [Potential] Solutions To A More Resilient Supply Chain
- 11.20.25 -- STREAM Edition: Adaptations To The Process And Scale-up
- 11.19.25 -- Find Small Molecule CDMOs Ready To Take On Your Next Project
- 11.18.25 -- Scaling Smarter In Biologics Manufacturing
INDUSTRY NEWS
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
-
![Dollar Icon from Medical pills-GettyImages-1708867150]( "Oregon Court Upholds Drug Price Transparency Law")
Oregon Court Upholds Drug Price Transparency LawThe law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Novartis To Add Small Molecule & Fill/Finish Capacity With North Carolina Drug Manufacturing Investments11/20/2025
Novartis Gene Therapies, a division of Switzerland-based Novartis, one of the world’s largest pharmaceutical companies, plans to expand in the Research Triangle with $771 million of investments at multiple locations, creating its first biologics drug substance facility in the United States and adding small molecule manufacturing and new fill/finish capabilities.
-
Halozyme Completes Acquisition Of Elektrofi, Expanding Breadth Of Offerings In Drug Delivery11/20/2025
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced the successful completion of its acquisition of Elektrofi, Inc. ("Elektrofi"), a biopharmaceutical company with a proprietary ultra-high concentration microparticle formulation technology for biologics, branded Hypercon™
-
Regeneron Announces Plans To Establish New Drug Manufacturing Facility In Saratoga Springs NY11/19/2025
Governor Kathy Hochul today announced that Regeneron Pharmaceuticals, a global leader in biotechnology founded in New York State, will create 1,000 new jobs as part of a $2 billion investment at its new facility in Saratoga Springs. The company plans to utilize a more than one million square foot property it recently purchased on Duplainville Road, which previously served as a printed material manufacturer. The project would encompass the design, reconstruction and fit-out of the existing space, with potential for additional expansion. Empire State Development has agreed to support Regeneron's plans and job creation goals with up to $35 million in performance-based Excelsior Jobs Program tax credits.
-
Novartis Expands U.S. footprint With New Radioligand Therapy Facility In California11/12/2025
Novartis, a leading global innovative medicines company, today announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California. This state-of-the-art site represents a key milestone in the company’s previously announced $23 billion investment in US infrastructure over the next five years.
-
AES Cleanroom Technology Establishes New Office In Research Triangle Park To Support Regional Drug Manufacturing Growth11/11/2025
AES Cleanroom Technology, an award-winning leader in modular cleanroom design and construction, has opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast’s fast-growing life sciences, biotechnology, and advanced manufacturing sectors.
